BNP Paribas Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$789K Buy
13,439
+11,638
+646% +$488K ﹤0.01% 1242
2026
Q1
$58K Buy
1,801
+537
+42% +$19.9K ﹤0.01% 1708
2025
Q4
$53K Buy
1,264
+328
+35% +$13.2K ﹤0.01% 1651
2025
Q3
$32K Hold
936
– – ﹤0.01% 1210
2025
Q2
$25K Buy
+936
New +$27.1K ﹤0.01% 1421

Other funds holding VCYT

BNP Paribas Asset Management's VCYT Position: Q2 2026 in Review

BNP Paribas Asset Management increased its Veracyte (VCYT) stake by 646% in Q2 2026, buying an estimated $488K and bringing the position to 13,439 shares worth $789K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

BNP Paribas Asset Management first reported a position in VCYT in Q2 2025 and has held it in 5 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • BNP Paribas Asset Management held 13,439 shares of Veracyte worth $789K as of Q2 2026.
  • BNP Paribas Asset Management bought 11,638 Veracyte shares in Q2 2026, an estimated $488K.
  • Veracyte made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #1242 holding.
  • BNP Paribas Asset Management first reported a position in Veracyte in Q2 2025 and has held it in 5 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.